Sharaf Kariem, Eggersmann Tanja K, Haider Stefan P, Schwenk-Zieger Sabina, Zhou Jiefu, Gires Olivier, Lechner Axel, Canis Martin, Haubner Frank
Department of Otolaryngology, University Hospital, LMU Munich, Marchioninistrasse 15, 81377 Munich, Germany.
Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistrasse 15, 81377 Munich, Germany.
Cancers (Basel). 2021 Jun 1;13(11):2751. doi: 10.3390/cancers13112751.
Human adipose-derived stem/stromal cells (ASCs) are increasingly used as auto-transplants in regenerative medicine to restore tissue defects or induce wound healing, especially in cancer patients. The impact of ASCs on squamous cell carcinoma of the upper aerodigestive tract (UAT) including head and neck and esophageal squamous cell carcinoma (HNSCC and ESCC) is not yet fully understood. ASCs were cultured from subcutaneous, abdominal lipoaspirates of five patients, who received auto-transplants to the head and neck. Supernatants were tested for paracrine effects in functional in vitro assays of proliferation of HNSCC tumor cell line FaDu and ESCC cell line Kyse30, and their cell migration/invasion capacities in Boyden chambers, in addition to endothelial tube formation assay using human umbilical vein endothelial cells (HUVECs). All ASC-derived supernatants enhanced proliferation of FaDu cells, invasive migration, and tube formation by HUVECs, compared to controls. Of five patients' lipoaspirates, ASC-derived supernatants of four patients increased proliferation and invasive migration in Kyse30 cells. The data suggests that ASCs can promote tumor cell proliferation, invasiveness, and neo-angiogenesis in these tumor cell lines of the UAT and HUVEC in a paracrine manner. Although clinical studies on the subject of oncological safety are still needed, these findings emphasize the importance of complete tumor removal before ASCs are used in the head and neck.
人脂肪来源的干细胞/基质细胞(ASCs)越来越多地被用作再生医学中的自体移植,以修复组织缺损或促进伤口愈合,尤其是在癌症患者中。ASCs对上消化道(UAT)鳞状细胞癌(包括头颈癌和食管鳞状细胞癌,即HNSCC和ESCC)的影响尚未完全了解。从5例接受头颈部自体移植患者的腹部皮下抽脂物中培养出ASCs。除了使用人脐静脉内皮细胞(HUVECs)进行内皮管形成试验外,还在体外功能试验中检测了上清液对HNSCC肿瘤细胞系FaDu和ESCC细胞系Kyse30增殖的旁分泌作用,以及它们在Boyden小室中的细胞迁移/侵袭能力。与对照组相比,所有ASC来源的上清液均增强了FaDu细胞的增殖、侵袭性迁移以及HUVECs的管形成。在5例患者的抽脂物中,4例患者的ASC来源上清液增加了Kyse30细胞的增殖和侵袭性迁移。数据表明,ASCs可以通过旁分泌方式促进UAT和HUVEC这些肿瘤细胞系中的肿瘤细胞增殖、侵袭性和新血管生成。尽管仍需要关于肿瘤学安全性的临床研究,但这些发现强调了在头颈部使用ASCs之前彻底切除肿瘤的重要性。